Tom Chivers During a conversation with a doctor a couple of years ago, the subject of cancer diagnoses came up, in a tangential way.
She said that not all that many decades ago, a physician who had established that a patient had cancer often wouldn’t bother investigating further: since there weren’t any effective treatments for any kind of cancer, there wasn’t much point in finding out what kind of cancer it was.
You could try to cut it out, or you could leave it in and see what happened, and that was about it. [read more]
In recent decades, obesity has reached epidemic proportions in populations whose environments promote physical inactivity and increased consumption of high-calorie foods. However, not all people living in such environments will become obese, nor will all obese people have the same body fat distribution or suffer the same health problems. These differences can be seen in groups of people with the same racial or ethnic background and even within families. Genetic changes in human populations occur too slowly to be responsible for the obesity epidemic. Nevertheless, the variation in how people respond to the same environment suggests that genes do play a role in the development of obesity. [Read More]
Ever wondered if you were born with that sweet tooth? Or if you are likely to gain weight back after dropping the kilos? A new test that is now available in Singapore promises to answer these questions – and more. Called the Pathway Fit test, it analyses a person’s genes to provide information about his metabolism, as well as the type of diet and exercise that would suit him best. [read more]
When Calista Mellos was born 10 years ago, her parents, Sherri and Peter Mellos, knew something was wrong. Unlike the typical noisy baby, Calista didn’t cry when she was hungry. She slept.
“We had to really work hard to wake her up,” said Sherri Mellos. “We’d have to take all of her clothes off, put a fan on her, put cold washcloths on her, and constantly rub her feet and face to keep her awake long enough to eat.” [read more]
Genetics research is at the forefront of the medical field today, with genome mapping at the spearhead expected to help combat genetic diseases in our time. More and more, genome sequencing is becoming standard practice for both clinicians and researchers, and the data compiled with this is enormous. With the aid of the cloud we are able to store and analyze the data in ways that previously would have been beyond imagination. [read more]
New research published recently in Genomics in Medicine has found that that many parents would be interested in having genomic sequencing for their newborn babies. This is the first study of its kind and initial results indicate that there would be a lot of interest among new parents if and when such newborn genomic testing becomes available. Parents’ interest in the testing was the same across all demographic backgrounds. [read more]
San Diego-headquartered genome mapping firm BioNano Genomics, Inc. says it has completed US$53 million series C financing led by Legend Capital and Novartis Venture Fund, according to a company announcement. [read more]
Under current regulations, location determines the changes we can make to human genomes and the degree to which we can sequence them. While it may seem like there is some ethical middle ground to which all countries would naturally converge, when one looks at the specifics, that is certainly not the case. [read more]